These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1759329)

  • 1. Determination of DNA ploidy and ABH antigen reactivity in both frozen and formalin-fixed bladder tumor tissue.
    Malmström PU; Vasko J; Wester K; Busch C
    Urol Res; 1991; 19(6):357-9. PubMed ID: 1759329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of blood group ABH antigen status and DNA ploidy as independent prognostic factor in transitional cell carcinoma of the urinary bladder.
    Malmström PU; Norlén BJ; Andersson B; Busch C
    Br J Urol; 1989 Jul; 64(1):49-55. PubMed ID: 2765768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABH isoantigens, histology and DNA ploidy in 36 consecutive patients with transitional cell bladder cancer. Status of tumor and biopsies taken from visually normal urothelium.
    Borgström E; Nyman C; Lönn M
    Urol Res; 1987; 15(4):199-202. PubMed ID: 3672667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric DNA ploidy analysis in canine transitional cell carcinoma of urinary bladders.
    Clemo FA; DeNicola DB; Carlton WW; Morrison WB; Walker E
    Vet Pathol; 1994 Mar; 31(2):207-15. PubMed ID: 8203084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of tissue ABH antigens in superficial bladder tumours.
    Tsujihashi H; Matsuda H; Uejima S; Akiyama T; Kurita T
    Int Urol Nephrol; 1991; 23(1):37-44. PubMed ID: 1938218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis of transitional cell bladder carcinoma. With special reference to ABH blood group isoantigen expression and DNA analysis.
    Malmström PU
    Scand J Urol Nephrol Suppl; 1988; 112():1-55. PubMed ID: 3068792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of flow cytometric deoxyribonucleic acid measurements of deparaffinized specimens in bladder tumors.
    Miao T; Wang Z; Sang N; Xiong R; Cao S
    Eur Urol; 1992; 21(2):98-102. PubMed ID: 1499623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deoxyribonucleic acid measurements in transitional cell carcinomas: comparison of flow and image cytometry techniques.
    Goulandris N; Karakitsos P; Georgoulakis J; Bellos C; Deliveliotis C; Legaki S
    J Urol; 1996 Sep; 156(3):958-60. PubMed ID: 8709372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective study of DNA ploidy of transitional cell carcinoma of urinary bladder using flow cytometry.
    Pan ST; Chan LP; Yu KC; Chang MC; Ho WL
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1994 Jan; 10(1):22-7. PubMed ID: 8176764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral heterogeneity in DNA ploidy of bladder carcinomas.
    Sasaki K; Hamano K; Kinjo M; Hara S
    Oncology; 1992; 49(3):219-22. PubMed ID: 1495749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of image analysis and flow cytometric measurements of DNA content of canine transitional cell carcinomas.
    Clemo FA; Crabtree WN; Walker E; DeNicola DB
    Anal Quant Cytol Histol; 1993 Dec; 15(6):418-26. PubMed ID: 8297432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABH secretor status in patients with bladder tumours.
    Paterson PJ
    Urol Res; 1976; 4(4):147-50. PubMed ID: 1020066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood group ABH-related antigens in normal and malignant bladder urothelium: possible structural basis for the deletion of type-2 chain ABH antigens in invasive carcinomas.
    Orntoft TF; Wolf H; Clausen H; Dabelsteen E; Hakomori S
    Int J Cancer; 1989 May; 43(5):774-80. PubMed ID: 2497072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a high risk subgroup of grade 1 transitional cell carcinoma using image analysis based deoxyribonucleic acid ploidy analysis of tumor tissue.
    Hemstreet GP; Rollins S; Jones P; Rao JY; Hurst RE; Bonner RB; Hewett T; Smith BG
    J Urol; 1991 Dec; 146(6):1525-9. PubMed ID: 1942333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The clinical significance of flow cytometric DNA measurement of paraffin specimen in bladder tumor].
    Wang Z
    Zhonghua Wai Ke Za Zhi; 1990 Aug; 28(8):505-8, 512. PubMed ID: 2086120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between the methods of indirect immunofluorescence and specific red cell adherence in detecting ABH iso-antigens in bladder carcinoma.
    Cooper HS; D'Elia FL
    Am J Clin Pathol; 1982 May; 77(5):548-54. PubMed ID: 7044101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific p53 gene mutations in urinary bladder epithelium after the Chernobyl accident.
    Yamamoto S; Romanenko A; Wei M; Masuda C; Zaparin W; Vinnichenko W; Vozianov A; Lee CC; Morimura K; Wanibuchi H; Tada M; Fukushima S
    Cancer Res; 1999 Aug; 59(15):3606-9. PubMed ID: 10446970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis in bladder cancer. A study of cytometric, morphometric and immunohistochemical techniques.
    Vaskó J
    Scand J Urol Nephrol Suppl; 1994; 160():1-73. PubMed ID: 7529427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of ABH blood group isoantigen and prognosis in patients with transitional cell bladder carcinoma.
    Malmström PU; Busch C; Norlen BJ
    Scand J Urol Nephrol Suppl; 1988; 110():205-11. PubMed ID: 3187409
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic factors in bladder cancer. A pathologic, immunohistochemical, and DNA flow-cytometric study.
    Lopez-Beltran A; Croghan GA; Croghan I; Matilla A; Gaeta JF
    Am J Clin Pathol; 1994 Jul; 102(1):109-14. PubMed ID: 8037155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.